Drugs in clinical trialRationale and design of the valsartan heart failure trial: A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure☆
References (24)
- et al.
Epidemiology of heart failure
Am Heart J
(1991) Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
Lancet
(1993)- et al.
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
Lancet
(1997) - et al.
Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor
Am J Cardiol
(1994) - et al.
Cardiac failure: a revised paradigm
J Card Fail
(1995) Effects of enalapril on mortality in severe congestive heart failure
New Engl J Med
(1987)Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
N Engl J Med
(1991)- et al.
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
N Engl J Med
(1991) - et al.
The effect of captopril on mortality and morbidity in patients with left ventricular dysfunction following myocardial infarction: Results of the Survival and Ventricular Enlargement (SAVE) trial
N Engl J Med
(1992) - et al.
A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction
N Engl J Med
(1995)
Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure
Circulation
(1978)
[SAR'] Angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells
Am J Physiol
(1990)
Cited by (140)
Waon therapy improves the prognosis of patients with chronic heart failure
2009, Journal of CardiologyIncremental value of renal function in risk prediction with the Seattle Heart Failure Model
2009, American Heart JournalACE2: A novel therapeutic target for cardiovascular diseases
2006, Progress in Biophysics and Molecular Biology
- ☆
Supported in part by a grant from Novartis.
Copyright © 1999 Published by Elsevier Inc.